SNDL Takes C$52 Million Goodwill Hit On Cannabis Operations, Opens Strategic Review

The charge pushed the third-quarter operating result to a C$48.3 million loss, while free cash flow set a quarterly record of C$20.0 million.

Share
SNDL Takes C$52 Million Goodwill Hit On Cannabis Operations, Opens Strategic Review

SNDL, the Edmonton-based liquor and cannabis retailer, posted a third-quarter operating loss of C$48.3 million after a C$52 million non-cash goodwill impairment on its Cannabis Operations segment, and said Tuesday it is starting a strategic review of that unit. Stripping out impairment and restructuring costs, adjusted operating income returned to C$5.2 million.

A loss driven by one segment

The operating loss compares with a loss of C$11.1 million a year earlier. Net revenue was C$238.0 million, down 2.5%: Cannabis Retail rose 0.7%, Liquor Retail fell 3.3% and Cannabis Operations fell 27.7%.

Gross margin slipped 2.0 percentage points to 24.3%, which the company blamed mainly on Cannabis Operations. Both retail segments set quarterly margin records. Cannabis Operations posted a negative gross margin of 6.0% and an operating loss of C$64.7 million.

SNDL said most of the segment's revenue drop came from its exit from the unprofitable domestic dried flower category. Beyond the impairment, it cited C$6 million of other hits, mostly inventory adjustments tied to that exit and Jeeter cost variances. It cut more than 30% of the workforce at its Kelowna manufacturing site.

Review of Cannabis Operations

CEO Zach George said the segment "remained below expectations" and that the review will weigh options "from potential asset divestitures to larger productivity initiatives." The company expects the cost cuts to begin contributing in the fourth quarter.

Record cash flow, buyback plans

Free cash flow reached a quarterly record of C$20.0 million, up 19.5% from a year earlier, including a C$10.6 million benefit from the initial unwinding of its captive insurance arrangement. Overall cash fell C$50.7 million, reflecting C$60.8 million of U.S. investments and C$10.0 million of share repurchases.

At September 30, SNDL held C$617.8 million of unrestricted cash, marketable securities and investments, including equity-accounted investees, and had no outstanding debt. Its board has directed management to pursue a possible substantial issuer bid of up to C$50 million at no more than C$1.92 (US$1.35) a share; fully subscribed at that price, it could cut shares outstanding by more than another 10%. The company also expects to renew its buyback when it expires on November 20, 2026, subject to board approval. U.S.-listed shares closed Monday at US$1.27.

Parallel stake and Ontario deal

Parallel's restructuring, completed July 27, cut its debt by about US$842 million, and a rights offering lifted SNDL's indirect equity stake from about 67% to about 92%. The company is exploring direct ownership of qualifying U.S. medical cannabis operations, subject to legal, regulatory, accounting and Nasdaq requirements.

SNDL also expects to settle regulatory matters with Ontario's Alcohol and Gaming Commission, pending definitive documents and a C$200,000 penalty. That would let Value Buds franchising resume in the province but deconsolidate the Ontario retail operations, while preserving the net economics, the company said.

The first test of the cost cuts comes with fourth-quarter results; the buyback renewal is slated for November 20, 2026.

Sources